AS2690168 (freebase)

CAT: 0804-HY-169857Size: 1 EachDry Ice: NoHazardous: No
CAT#:0804-HY-169857Size:1 Each
Selected
PRICE
AVAILABILITY: InStock
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Product image 1
1 / 1
Description
AS2690168 freebase is an orally active RANKL signal transduction inhibitor which suppresses RANKL-induced osteoclastogenesis of RAW264 cells. AS2690168 can be utilized in research related to pathological osteolysis[1].
CAS Number
[1393999-78-4]
UNSPSC
12352005
Target
RANKL/RANK
Related Pathways
NF-κB
Field of Research
Others
Smiles
FC1=CC(F)=C(CNC2=C(OC)C=NC(C3=NC=CC=C3)=N2)C(F)=C1
Molecular Formula
C17H13F3N4O
Molecular Weight
346.31
References & Citations
[1]Morikawa N, et al. Pharmacological characterization of AS2690168, a novel small molecule RANKL signal transduction inhibitor. Eur J Pharmacol. 2022 Jun 5;924:174941.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported

Related Products

CatalogName
HY-169857AAS2690168 (hydrochloride)

Alternative Products

CatalogName
MF-0063279-01AS2690168 hydrochloride
MBS3603731-01BCX4430 freebase
MF-0063278-01AS2690168 (free base)
206700Quizartinib freebase
A10770-50R406 (freebase) 50mg
A10770-100R406 (freebase) 100mg
M23528-01PF-5274857 freebase
A10770-25R406 (freebase) 25mg
M11132-01APX-115 freebase
584642GDC-0575 freebase

Popular Products